Atom Grants
Discover
  • Dashboard
  • Search
  • Deep Research
  • Favorites
  • Projects

    Laughlin Family Foundation Research Grant for High-Grade Uterine Cancer

    Forecasted

    Laughlin Family Foundation Research Grant for High-Grade Uterine Cancer supports researchers studying treatment resistance in high-grade endometrial cancer to advance more durable, personalized care.

    Browse similar grants
    Cancer Research Grants 2026
    OverviewSimilar Grants
    OverviewSimilar Grants

    Funder: Foundation for Women's Cancer

    Due Dates (Anticipated): December 2026 (Full proposals) | October 2027 (LOI)

    Funding Amounts: $50,000 for one year

    Summary: Supports innovative research addressing therapeutic resistance and advancing treatment of high-grade endometrial cancer.

    Key Information: Research must take place at a U.S. institution; applicants need SGO membership, an SGO-member co-investigator, or SGO sponsorship.


    Description

    Funded by the Laughlin Family Foundation and administered through the Foundation for Women’s Cancer (FWC), this opportunity supports innovative research advancing treatment of high-grade endometrial cancer, particularly the challenge of therapeutic resistance. It is the Laughlin Family Foundation’s fourth FWC research grant for high-grade uterine cancer.

    Research may investigate hormonal or endocrine resistance, immune escape, lineage plasticity, tumor-microenvironment interactions, the microbiome’s role in inflammation and treatment response, or biomarkers predicting responsiveness to current or emerging therapies. Priority goes to projects using cutting-edge technologies and translational approaches to identify actionable targets and accelerate therapeutic development. The goal is more durable, personalized care for patients with aggressive endometrial cancers.


    Atom

    See the full grant listing

    Sign in to view full eligibility details, sources, similar grants, and AI-powered analysis.